about
Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancerOverexpressed oncogenic tumor-self antigensPostoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma.Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patientsCell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application.Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens.Immunological monitoring of anticancer vaccines in clinical trials.
P2860
Q33587863-2199333E-7FC4-407D-903C-BEE91791139BQ35886756-91795977-E674-489E-947C-78AA54221254Q36977760-DB78F029-2F5A-4A88-AC12-462C896F9758Q37530591-960AC5D7-1D52-42AB-9CE7-AF94E3596EF5Q37612333-016AB989-3ED3-48F0-B0EB-6ABC9EDEEDDAQ42079459-C7AAC853-453E-4333-BA8F-8123DCCFA868Q42734281-8B453C6D-8024-4356-8EA9-6E839D1968D1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical evaluation of therapeutic cancer vaccines.
@en
Clinical evaluation of therapeutic cancer vaccines.
@nl
type
label
Clinical evaluation of therapeutic cancer vaccines.
@en
Clinical evaluation of therapeutic cancer vaccines.
@nl
prefLabel
Clinical evaluation of therapeutic cancer vaccines.
@en
Clinical evaluation of therapeutic cancer vaccines.
@nl
P2860
P356
P1476
Clinical evaluation of therapeutic cancer vaccines.
@en
P2093
Atsushi Aruga
Chizuru Ogi
P2860
P304
P356
10.4161/HV.23917
P577
2013-03-01T00:00:00Z